We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

VAXIMM Starts Clinical Study of First Oral Cancer Vaccine

News   Dec 13, 2011

 
VAXIMM Starts Clinical Study of First Oral Cancer Vaccine
 
 
Advertisement
 

RELATED ARTICLES

Nanoparticle-Infused Contact Lenses Correct Color Blindness

News

Dyed contact lenses currently in development for color blindness are potentially harmful and unstable. Now, researchers have infused contact lenses with gold nanoparticles to create a safer way to see colors.

READ MORE

Drug Shown To Help Diabetes Patients Lose Weight in Clinical Study

News

In a multicenter Phase 3 clinical study, the drug semaglutide was shown to help patients with diabetes lose on average 10 to 17% of their body weight.

READ MORE

Using Viruses To Train the Immune System To Tackle Tumors

News

A research group has developed a strategy that is being tested in clinical studies for therapeutic cancer vaccines. Using two different viruses as vehicles, they administered specific tumor components in mice with cancer in order to stimulate their immune system to attack the tumor.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE